How to Buy Keros Therapeutics Stock
Keros Therapeutics Inc
Keros Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need.
Keros Therapeutics stock last closed at $14.76, down 5.14% from the previous day, and has decreased 67.5% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. Keros Therapeutics stock is currently +61.84% from its 52-week low of $9.12, and -79.6% from its 52-week high of $72.37.
There are currently 40.62M shares of KROS outstanding. The market value of KROS is $599.48M. In the last 24 hours, 294,000 KROS shares were traded.
How to Buy Keros Therapeutics Stock
Wondering how to invest in Keros Therapeutics stock? Here's how.
- Figure out where to buy Keros Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Keros Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your method of payment and add your info.
- Research Keros Therapeutics stock: The Keros Therapeutics ticker symbol is KROS. Is Keros Therapeutics stock a good investment? Should you buy shares of KROS? How do KROS's underlying business fundamentals look? Do top analysts think Keros Therapeutics is a good buy? Why has KROS's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if KROS is a good stock to buy).
- Place your KROS purchase: Decide if you will purchase KROS shares at the current market price or use a limit order to purchase KROS shares at a specific price.
- Monitor your investment in KROS: Create a watchlist to the latest updates on your position in Keros Therapeutics shares.
Step 1: Figure out where to buy Keros Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy KROS shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to invest in KROS stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new brokerage account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of transferring funds into your brokerage account.
Step 4: Research Keros Therapeutics stock
Once you have identified the best place to buy Keros Therapeutics stock, it's very important to analyze their stock before you invest, so you truly comprehend the risk and opportunity.
Keros Therapeutics shares at a glance
Fundamentals of KROS
WallStreetZen was designed to help part-time investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on KROS's stock page.
Is KROS stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge KROS's true value.
Using relative valuations metrics:
- KROS may be undervalued based on its P/E ratio of 39.89x, relative to Biotechnology industry P/E ratio of -111.34x
- KROS may be undervalued based on its P/B ratio of 0.85x, relative to Biotechnology industry P/B ratio of 4.53x
You can do additional valuation analysis on KROS's stock here.
Is KROS a healthy company?
Signs that KROS is financially healthy:
- KROS has a low debt to equity ratio of 0.07.
- There are more short-term assets than short-term liabilities on the KROS balance sheet.
- KROS earnings of $26.89M is not sufficient to cover its interest payments.
- KROS profit margin has gone up from -62,012.5% to 8.1% in the past year.
- KROS's operating cash flow of $55.04M allows it to safely service it's debt of $17.95M.
- There are more short-term assets than long-term liabilities on the KROS balance sheet.
Signs that KROS is not financially healthy:
- Total KROS debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy KROS stock
Out of 7 Equities analysts who give recommendations on KROS, the consensus analyst rating on Keros Therapeutics is a Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent KROS Analyst Forecasts
Srikripa Devarakonda, a bottom 8% analyst from Truist Securities maintains KROS with a strong buy rating and lowers their KROS price target from $43.00 to $25.00, on Apr 9, 2025.
Tiago Fauth, a top 39% analyst from Wells Fargo maintains KROS with a strong buy rating and lowers their KROS price target from $28.00 to $26.00, on Feb 27, 2025.
You can dig deeper into what analysts are saying on the Keros Therapeutics stock forecast page.
KROS Trading Indicators
KROS Revenue
Last year, KROS revenue was $232.84M. During the past 5 year, KROS's revenue has gone up by 115.59% per year. This was faster than the Biotechnology industry average of 65.04%.
You can research KROS's earnings and revenue performance here.
Are KROS executives and large shareholders buying or selling the stock?
Over the past 12 months, insiders at KROS have bought more shares than they have sold.
Adar1 Capital Management LLC, 10% Owner of KROS, was the latest KROS insider to sell. They sold $6,000.00 worth of KROS stock on Jun 20, 2025.
Get more info about who owns KROS stock here.
Can I get consistent income from KROS stock?
No, Keros Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about KROS
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your KROS purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and eToro will execute your order.
If you want additional help with buying stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in KROS
Now that you own some KROS shares, you'll want to stay up-to-date on your investment.
Put KROS on a watchlist to keep track of your KROS stock.
KROS Feed
How to Buy Stock in Keros Therapeutics
To reiterate, here are the 6 steps for buying Keros Therapeutics stock:
- Figure out where to buy Keros Therapeutics stock
- Open a brokerage account
- Deposit funds into your investment account
- Research Keros Therapeutics stock
- Place your KROS purchase
- Monitor your investment in KROS
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Keros Therapeutics, create your watchlist below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.